MicroRNA-200, associated with metastatic breast cancer, promotes traits of mammary luminal progenitor cells.

TitleMicroRNA-200, associated with metastatic breast cancer, promotes traits of mammary luminal progenitor cells.
Publication TypeJournal Article
Year of Publication2017
AuthorsSánchez-Cid, L, Pons, M, Lozano, JJosé, Rubio, N, Guerra-Rebollo, M, Soriano, A, Paris-Coderch, L, Segura, MF, Fueyo, R, Arguimbau, J, Zodda, E, Bermudo, R, Alonso, I, Caparrós, X, Cascante, M, Rafii, A, Kang, Y, Martínez-Balbás, M, Weiss, SJ, Blanco, J, Muñoz, M, Fernández, PL, Thomson, TM
Date Published2017 Oct 13

<p>MicroRNAs are critical regulators of gene networks in normal and abnormal biological processes. Focusing on invasive ductal breast cancer (IDC), we have found dysregulated expression in tumor samples of several microRNAs, including the miR-200 family, along progression from primary tumors to distant metastases, further reflected in higher blood levels of miR-200b and miR-7 in IDC patients with regional or distant metastases relative to patients with primary node-negative tumors. Forced expression of miR-200s in MCF10CA1h mammary cells induced an enhanced epithelial program, aldehyde dehydrogenase (ALDH) activity, mammosphere growth and ability to form branched tubuloalveolar structures while promoting orthotopic tumor growth and lung colonization . MiR-200s also induced the constitutive activation of the PI3K-Akt signaling through downregulation of PTEN, and the enhanced mammosphere growth and ALDH activity induced in MCF10CA1h cells by miR-200s required the activation of this signaling pathway. Interestingly, the morphology of tumors formed by cells expressing miR-200s was reminiscent of metaplastic breast cancer (MBC). Indeed, the epithelial components of MBC samples expressed significantly higher levels of miR-200s than their mesenchymal components and displayed a marker profile compatible with luminal progenitor cells. We propose that microRNAs of the miR-200 family promote traits of highly proliferative breast luminal progenitor cells, thereby exacerbating the growth and metastatic properties of transformed mammary epithelial cells.</p>

Alternate JournalOncotarget
PubMed ID29137351
PubMed Central IDPMC5663523